MH3D Inc. is a medical device startup specializing in the development of high-resolution and high-sensitivity Single Photon Emission Computed Tomography (SPECT) systems for accurate functional imaging of brain tumors (e.g., glioblastoma) at sub 1mm level. Our mission is to address the unmet clinical need of enhancing the accuracy and timeliness of brain cancer diagnosis, optimizing tumor resection success rates, and facilitating precise cancer progression monitoring to ultimately elevate survival rates across all age groups.